Abstract: A process for reforming alkyleneamines to predominantly linearly-extended polyalkylenepolyamines comprising contacting an alkyleneamine or mixture thereof with a catalyst under conditions such that a mixture of polyalkylenepolyamines enriched in linearly-extended products is formed, said catalyst containing at least one compound selected from the group consisting of (a) Group VB metal oxides, (b) Group VB metal phosphates, (c) silicates of Groups IIA, IIIB, IVB, VB, and the lanthanide and actinide metals, and (d) tungsten oxdies, with the proviso that the silicates and tungsten oxides are essentially free of aluminum. For example, ethylenediamine is contacted with a catalyst of niobium phosphate or niobic acid under reaction conditions to yield predominantly non-cyclic polyethylenepolyamines.

Abstract: The synthesis of novel ethanesulfonamide compounds is described. The novel ethanesulfonamide compounds have antisecretory activity and are used in the treatment of peptic ulcer disease. The intermediates used to prepare the ethanesulfonamides are useful in the treatment of osteoporosis and other bone wasting diseases.

Abstract: This application relates to a process for preparing a N-t-alkyl-1,2-diacylhydrazine by reacting a 1,3,4-oxadiazole with a tertiary alkyl cation precursor in the presence of a strong acid catalyst. Preferably, the 1,3,4-oxadiazole is a 2,5-disubstituted-1,3,4-oxadiazole and more preferably a 2,5-diaryl-1,3,4-oxadiazole. The strong acid catalyst is preferably a sulfur containing acid and more preferably sulfuric acid.

Abstract: A method of preparing solid hydroxyalkylamides by reacting carboxylic alkyl esters with alkanolamines at controlled reaction temperatures, removing the alcohol byproduct, controlling the temperature of the reaction mixture to form a slurry, maintaining the slurry and recovering the solid hydroxyalkylamides.

Abstract: 5,6-Dimethoxy-2-[2-(4-hydroxyphenyl)-2-hydroxy-2-methylethyl]amino- 1,2,3,4-tetrahydronaphthalene has inotropic and vasodilating activities and therefore can be used in the treatment of cardiocirculatory failure. The compound can be in the form of a single stereoisomer or as a mixture of two or more stereoisomers.

Abstract: The novel copper catalyst on an Al.sub.2 O.sub.3 -containing carrier which is impregnated with compounds of manganese and of one or more rare earth metals, having a Cu content of 0.1-5% by weight, a total content of compounds of manganese and of the rare earth metal or metals of 0.05 to 8% by weight, calculated as metals, is described, the weight ratio of rare earth metal(s) to manganese being 5:1-1:5, calculated as metal, and all percentages being relative to the total weight of the catalyst. Such catalyst is prepared by first impregnating the carrier with compounds of manganese and of the rare earth metal or metals, then fixing the copper salt on the impregnated carrier and activating the catalyst in a preferred manner by treatment with H.sub.2 at 150.degree. to 350.degree. C. Such a catalyst is suitable, for example, for the N-alkylation of aromatic amines with alkanols, where the aromatic amines can be prepared from the parent nitro compounds in an alkylation reactor with simultaneous addition of H.sub.2.

Abstract: High molecular weight secondary amine terminated amides are disclosed which are prepared by a two-step process wherein a triamine and dibasic acid are reacted to form an acid terminated amide intermediate which is further reacted with a polyethylene glycol diamine or N,N'-diisopropyl derivative thereof to form an ungelled amine terminated product which is useful as an epoxy curing agent.The product can be represented by the following structure: ##STR1## where x=1 to 5 and R"=H or C.sub.1 to C.sub.4 carbon atoms.

Abstract: Novel thiol-terminated hydroxyamides, and processes for their preparation and use are provided. These hydroxyamide compounds may be prepared by the reaction of a mercapto-functional alkyl ester, such as methylmercaptopropionate, with a molar excess of an alcohol-substituted amine, such as a .beta.-hydroxyalkyl amine. The thiol-terminated hydroxyamides are useful as polymerization chain transfer agents, particularly when it is desirable to form polymers or oligomers containing functional hydroxyamide end groups. By chain terminating such polymers or oligomers with reactive hydroxyamide end groups the polymers or oligomers can be further reacted with acid-containing monomers or polymers to form block or graft copolymers.

Abstract: A process for producing .alpha.-hydroisobutyric acid amide by a hydration reaction of acetonecyanohydrin in the presence of a catalyst containing manganese dioxide as a main component, and also in the presence of an oxidizing agent. In accordance with the process, the service life of the catalyst is increased, and the .alpha.-hydroxyisobutyric acid amide is produced in a high yield.

Abstract: A method of preparing a hexaalkylguanidinium salt comprising contacting tetraalkylguanidine with an alkylating agent in the presence of at least one alkaline reagent, and optionally, a promoting amount of a phase transfer catalyst.

Abstract: A process for the preparation of S- or R-carbazole derivatives of the general formula: ##STR1## in which R is an unsubstituted or substituted amino radical and pharmacologically acceptable salts, by either reacting R-(-)-epichlorohydrin (for the S-carbozole derivative); or reacting an S-epoxide derivative of the general formula: ##STR2## in which R.sub.1 is the residue of a substituted sulphonic acid derivative (for the R-carbazole derivative); with 4-hydroxycarbazole and then with ammonia or a substituted amine of the general formula RH, and recovering the compound or converting it to a pharmacologically acceptable salt.The new R-(+)- and S(-)-carbazole derivatives provided by the inventive process have unexpected beta blocking and vasodilatory properties and are useful in pharmaceutical compositions. R-(+)-carbazole derivatives are also useful for the treatment of glaucoma.

Abstract: Novel herbicides and plant growth regulants of the formula ##STR1## in which R.sup.1 represents hydrogen alkyl, alkenyl, alkinyl, halogenoalkyl, halogenoalkenyl, halogenoalkinyl, alkoxyalkyl, alkoxy, cycloalkylalkyl or cycloalkyl, or represents in each case optionally substituted aralkyl or aryl,R.sup.2 represents a radical ##STR2## or represents a radical --S(O).sub.n --R.sup.7, R.sup.3 and R.sup.

Abstract: Anilines or N-alkyl-anilines are advantageously reacted with alkyl alcohols or the associated dialkyl ethers at elevated temperature in the gas phase, if a .gamma.-Al.sub.2 O.sub.3 is used that is prepared by dehydration of an aluminum oxide/hydroxide hydrate and has a BET surface area from 50 to 400 m.sup.2 /g and a surface acidity of 5 to 600 mmol H.sup.+ /kg.

Abstract: N-alkylamide of DL and L(-)-carnitine having general formula (I) ##STR1## wherein: x.sup.- is OH.sup.- or the anion of a pharmacologically acceptable acid (preferably Cl.sup.-`), andR is a straight C.sub.10 -C.sub.16 alkyl radicalare prepared via transamination by reacting DL or L(-)-carnitinamide halogenide with an amine of formula NH.sub.2 R wherein R has the above-identified meaning in an acid environment (e.g. H.sub.3 PO.sub.4) in the presence of a high-boiling solvent (e.g. ethylene glycol).N-alkylamides (I) are endowed with potent antibacterial activity and are suitable for preparing pharmaceutical and cosmetic compositions.

Abstract: Aqueous alkanolamine solution containing alkali metal salts of anions which form heat stable salts with such alkanolamine is reactivated by contacting the solution sequentially with a basic anion exchange resin to remove such anions and an acidic cation ion exchange resin to remove alkali metal ions.

Abstract: Process for the preparation of 4-chloro-2,5-dimethoxyaniline by catalytic reduction of 4-chloro-2,5-dimethoxynitrobenzene with hydrogen in the liquid phase at an elevated temperature and elevated pressure, which comprises carrying out the reduction at temperatures from about 80.degree. to about 110.degree. C. and under a pressure of about 5 to 50 atmospheres gauge in an aromatic solvent in the presence of a modified platinum-on-carbon catalyst in the presence of about 0.01 to about 0.2 mole of a compound which gives a pH of 8 to 10 in aqueous solution, and in the presence of about 0.1 to about 1.0% by weight of an aliphatic, open-chain, primary, secondary or tertiary amine or a cyclic amine, in each case relative to the amount in moles and weight, respectively, of 4-chloro-2,5-dimethoxynitrobenzene employed.

Abstract: An amine is produced by reacting in the presence of hydrogen at elevated temperature a first reactant which is a compound substantially involatile at the elevated temperature employed and having either one, two or more hydroxyl functions, each of which is independently either a primary or secondary hydroxyl function, with a second reactant which is either ammonia or a primary or a secondary amine in the presence of a reductive amination catalyst wherein the reaction is effected in either a continuously or periodically open system.

Abstract: Novel 2-[(meth)acrylamidomethyl]-1,3-diketones have the general formula (I) ##STR1## where R is hydrogen or methyl,R.sup.1 is hydrogen, methyl or ethyl,R.sup.2 and R.sup.3 are each alkyl of from 1 to 6 carbon atoms or unsubstituted or substituted aryl of from 6 to 20 carbon atoms, R.sup.2 and R.sup.3 being identical to or different from each other.

Abstract: A process for the preparation of predominantly non-cyclic polyalkylenepolyamines comprising contacting a difunctional aliphatic alcohol with ammonia or a primary or secondary aliphatic amine in the presence of a catalyst selected from the group consisting of Group VB metal oxides, niobium phosphates, tantalum phosphates, and mixtures thereof. For example, monoethanolamine is aminated by ethylenediamine to predominantly linear and branched polyethylenepolyamines in the presence of a catalyst containing niobium oxide supported on boehmite alumina.

Abstract: New N-(2-cycloalkylamino)ethyl-substituted benzamides having a powerful stimulating activity on gastric motility and with a low central anti-dopaminergic activity are described. The synthesis and the pharmaceutical preparation for therapeutical use are also described.